Works by Adams, Hugo J. A.

Results: 39

Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?

Published in:

2016

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Letter to the Editor

Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at?

Published in:

Acta Oncologica, 2018, v. 57, n. 8, p. 1128, doi. 10.1080/0284186X.2018.1441541

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Debate on the value of end-of-treatment FDG-PET response evaluation in follicular lymphoma.

Published in:

2017

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Letter to the Editor

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study.

Published in:

Acta Oncologica, 2016, v. 55, n. 3, p. 386, doi. 10.3109/0284186X.2015.1041652

By:

Adams, Hugo J. A.;
de Klerk, John M. H.;
Fijnheer, Rob;
Heggelman, Ben G. F.;
Dubois, Stefan V.;
Nievelstein, Rutger A. J.;
Kwee, Thomas C.

Publication type:

Article

Bone marrow biopsy in diffuse large B-cell lymphoma: Useful or redundant test?

Published in:

Acta Oncologica, 2015, v. 54, n. 1, p. 67, doi. 10.3109/0284186X.2014.958531

By:

Adams, Hugo J. A.;
de Klerk, John M. H.;
Fijnheer, Rob;
Heggelman, Ben G. F.;
Dubois, Stefan V.;
Nievelstein, Rutger A. J.;
Kwee, Thomas C.

Publication type:

Article

Surveillance MRI for the detection of locally recurrent Ewing sarcoma seems futile.

Published in:

2018

By:

Kasalak, Ömer;
Dammann, Amelie;
Adams, Hugo J. A.;
Overbosch, Jelle;
Dierckx, Rudi A. J. O.;
Jutte, Paul C.;
Kwee, Thomas C.

Publication type:

journal article

Culture yield of repeat percutaneous image-guided biopsy after a negative initial biopsy in suspected spondylodiscitis: a systematic review.

Published in:

2018

By:

Kasalak, Ömer;
Adams, Hugo J. A.;
Jutte, Paul C.;
Overbosch, Jelle;
Dierckx, Rudi A. J. O.;
Wouthuyzen-Bakker, Marjan;
Kwee, Thomas C.

Publication type:

journal article

CT-guided biopsy in suspected spondylodiscitis: microbiological yield, impact on antimicrobial treatment, and relationship with outcome.

Published in:

2018

By:

Kasalak, Ömer;
Wouthuyzen-Bakker, Marjan;
Adams, Hugo J. A.;
Overbosch, Jelle;
Dierckx, Rudi A. J. O.;
Jutte, Paul C.;
Kwee, Thomas C.

Publication type:

journal article

Interim PET in Hodgkin Lymphoma: Is It So Useless?

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1180, doi. 10.2967/jnumed.117.190462

By:

Meignan, Michel;
Cottereau, Anne Ségolène;
Deau, Bénédicte;
Kanoun, Salim;
Berriolo-Riedinger, Alina;
Casasnovas, Olivier;
Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Fact Sheet About Interim and End-of-Treatment 18F-FDG PET/CT in Lymphoma.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1178, doi. 10.2967/jnumed.116.187815

By:

Adams, Hugo J. A.;
Kwee, Thomas C.;
Kostakoglu, Lale

Publication type:

Article

Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma.

Published in:

Journal of Nuclear Medicine, 2017, v. 58, n. 4, p. 684, doi. 10.2967/jnumed.116.186023

By:

Adams, Hugo J. A.;
Kwee, Thomas C.;
Bhethanabhotla, Sainath;
Bakhshi, Sameer

Publication type:

Article

Critical Views on the Prognostic Potential and Interpretation of Bone Marrow 18F-FDG PET in Diffuse Large B-Cell Lymphoma.

Published in:

Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 163, doi. 10.2967/jnumed.114.148577

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: 18F-FDG PET, MR Imaging, or 8F-FDG PET/MR Imaging?

Published in:

Journal of Nuclear Medicine, 2013, v. 54, n. 11, p. 2017, doi. 10.2967/jnumed.113.126797

By:

Adams, Hugo J. A.;
Kwee, Thomas C.;
Nievelstein, Rutger A. J.

Publication type:

Article

Interim FDG-PET in lymphoma, a questionable practice in hematology.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 12, p. 2014, doi. 10.1007/s00259-017-3783-4

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.

Published in:

2018

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Letter

Assessing baseline bone marrow status in advanced-stage Hodgkin lymphoma: does it have any purpose?

Published in:

2017

By:

Adams, Hugo;
Kwee, Thomas;
Adams, Hugo J A;
Kwee, Thomas C

Publication type:

Letter

End-of-treatment FDG-PET lacks usefulness in Hodgkin lymphoma.

Published in:

2016

By:

Adams, Hugo;
Kwee, Thomas;
Adams, Hugo J A;
Kwee, Thomas C

Publication type:

Letter

No convincing evidence to support postinduction FDG-PET in follicular lymphoma.

Published in:

2016

By:

Adams, Hugo;
Kwee, Thomas;
Adams, Hugo J A;
Kwee, Thomas C

Publication type:

Letter

Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma.

Published in:

2016

By:

Adams, Hugo;
Kwee, Thomas;
Adams, Hugo J A;
Kwee, Thomas C

Publication type:

Letter

Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis.

Published in:

2016

By:

Adams, Hugo;
Kwee, Thomas;
Adams, Hugo J A;
Kwee, Thomas C

Publication type:

journal article

Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy.

Published in:

2016

By:

Adams, Hugo;
Nievelstein, Rutger;
Kwee, Thomas;
Adams, Hugo J A;
Nievelstein, Rutger A J;
Kwee, Thomas C

Publication type:

journal article

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review.

Published in:

2016

By:

Adams, Hugo;
Nievelstein, Rutger;
Kwee, Thomas;
Adams, Hugo J A;
Nievelstein, Rutger A J;
Kwee, Thomas C

Publication type:

journal article

Interim FDG‐PET does not predict outcome in advanced‐stage Hodgkin lymphoma patients treated with BEACOPP.

Published in:

British Journal of Haematology, 2019, v. 185, n. 4, p. 758, doi. 10.1111/bjh.15602

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Assessing complete remission status in incurable follicular lymphomas, to what purpose?

Published in:

British Journal of Haematology, 2019, v. 184, n. 3, p. 467, doi. 10.1111/bjh.15114

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Post‐ABVD biopsy results, and not post‐ABVD FDG‐PET results, predict outcome in early‐stage Hodgkin lymphoma.

Published in:

British Journal of Haematology, 2019, v. 184, n. 2, p. 290, doi. 10.1111/bjh.15071

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Interim FDG‐PET has no value in selecting patients who require treatment modification in both early‐ and advanced‐stage Hodgkin lymphoma.

Published in:

British Journal of Haematology, 2018, v. 183, n. 1, p. 129, doi. 10.1111/bjh.14906

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Hodgkin lymphoma: is there really a need for interim and end‐of‐treatment FDG‐PET evaluations?

Published in:

2018

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Letter to the Editor

Overestimated value of FDG- PET based bone marrow evaluation in lymphoma.

Published in:

British Journal of Haematology, 2017, v. 179, n. 2, p. 336, doi. 10.1111/bjh.14217

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Does end-of-treatment FDG- PET provide any additional prognostic value to the pre-treatment NCCN- IPI score?

Published in:

British Journal of Haematology, 2017, v. 177, n. 2, p. 319, doi. 10.1111/bjh.14052

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis.

Published in:

British Journal of Haematology, 2015, v. 170, n. 3, p. 356, doi. 10.1111/bjh.13441

By:

Adams, Hugo J. A.;
Nievelstein, Rutger A. J.;
Kwee, Thomas C.

Publication type:

Article

Prognostic value of complete remission status at end-oftreatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.

Published in:

British Journal of Haematology, 2015, v. 170, n. 2, p. 185, doi. 10.1111/bjh.13420

By:

Adams, Hugo J. A.;
Nievelstein, Rutger A. J.;
Kwee, Thomas C.

Publication type:

Article

Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis.

Published in:

European Radiology, 2021, v. 31, n. 11, p. 8168, doi. 10.1007/s00330-021-08003-8

By:

Kwee, Robert M.;
Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Pretransplant FDG- PET in aggressive non-Hodgkin lymphoma: systematic review and meta-analysis.

Published in:

European Journal of Haematology, 2017, v. 98, n. 4, p. 337, doi. 10.1111/ejh.12837

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Controversies on the prognostic value of interim FDG- PET in advanced-stage Hodgkin lymphoma.

Published in:

European Journal of Haematology, 2016, v. 97, n. 6, p. 491, doi. 10.1111/ejh.12791

By:

Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Article

Peer review practices by medical imaging journals.

Published in:

Insights into Imaging, 2020, v. 11, n. 1, p. 1, doi. 10.1186/s13244-020-00921-3

By:

Kwee, Thomas C.;
Adams, Hugo J. A.;
Kwee, Robert M.

Publication type:

Article

Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis.

Published in:

2019

By:

Kasalak, Ömer;
Overbosch, Jelle;
Adams, Hugo J. A.;
Dammann, Amelie;
Dierckx, Rudi A. J. O.;
Jutte, Paul C.;
Kwee, Thomas C.;
Adams, Hugo Ja;
Dierckx, Rudi Ajo

Publication type:

journal article

Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.

Published in:

2016

By:

Adams, Hugo J. A.;
de Klerk, John M. H.;
Fijnheer, Rob;
Heggelman, Ben G. F.;
Dubois, Stefan V.;
Nievelstein, Rutger A. J.;
Kwee, Thomas C.;
Adams, Hugo Ja;
de Klerk, John Mh;
Heggelman, Ben Gf;
Nievelstein, Rutger Aj

Publication type:

journal article

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

Published in:

2015

By:

Adams, Hugo Ja;
Kwee, Thomas C;
Fijnheer, Rob;
Dubois, Stefan V;
Nievelstein, Rutger Aj;
de Klerk, John Mh;
Adams, Hugo J A;
Nievelstein, Rutger A J;
de Klerk, John M H

Publication type:

journal article

Are Researchers Willing to Share Their Published Manuscript?

Published in:

2020

By:

Alkhawtani, Rayan H. M.;
Adams, Hugo J. A.;
Kwee, Thomas C.

Publication type:

Letter

Works by Adams, Hugo J. A.

Will treatment intensification in early-stage Hodgkin lymphoma patients with a positive interim FDG-PET improve outcome?

Interim FDG-PET/CT in Hodgkin lymphoma: what are we actually looking at?

Debate on the value of end-of-treatment FDG-PET response evaluation in follicular lymphoma.

Lymphoma grading with FDG-PET/CT readdressed: Direct and timely histopathological correlation study.

Bone marrow biopsy in diffuse large B-cell lymphoma: Useful or redundant test?

Surveillance MRI for the detection of locally recurrent Ewing sarcoma seems futile.

Culture yield of repeat percutaneous image-guided biopsy after a negative initial biopsy in suspected spondylodiscitis: a systematic review.

CT-guided biopsy in suspected spondylodiscitis: microbiological yield, impact on antimicrobial treatment, and relationship with outcome.

Interim PET in Hodgkin Lymphoma: Is It So Useless?

Fact Sheet About Interim and End-of-Treatment <sup>18</sup>F-FDG PET/CT in Lymphoma.

Neither Posttreatment PET/CT Nor Interim PET/CT Using Deauville Criteria Predicts Outcome in Pediatric Hodgkin Lymphoma.

Critical Views on the Prognostic Potential and Interpretation of Bone Marrow <sup>18</sup>F-FDG PET in Diffuse Large B-Cell Lymphoma.

Prognostic Implications of Imaging-Based Bone Marrow Assessment in Lymphoma: <sup>18</sup>F-FDG PET, MR Imaging, or 8F-FDG PET/MR Imaging?

Interim FDG-PET in lymphoma, a questionable practice in hematology.

The Deauville criteria cannot differentiate between responding and non-responding non-Hodgkin lymphoma patients.

Assessing baseline bone marrow status in advanced-stage Hodgkin lymphoma: does it have any purpose?

End-of-treatment FDG-PET lacks usefulness in Hodgkin lymphoma.

No convincing evidence to support postinduction FDG-PET in follicular lymphoma.

Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma.

Prognostic value of pretransplant FDG-PET in refractory/relapsed Hodgkin lymphoma treated with autologous stem cell transplantation: systematic review and meta-analysis.

Systematic review and meta-analysis on the prognostic value of complete remission status at FDG-PET in Hodgkin lymphoma after completion of first-line therapy.

Prognostic value of interim and end-of-treatment FDG-PET in follicular lymphoma: a systematic review.

Interim FDG‐PET does not predict outcome in advanced‐stage Hodgkin lymphoma patients treated with BEACOPP.

Assessing complete remission status in incurable follicular lymphomas, to what purpose?

Post‐ABVD biopsy results, and not post‐ABVD FDG‐PET results, predict outcome in early‐stage Hodgkin lymphoma.

Interim FDG‐PET has no value in selecting patients who require treatment modification in both early‐ and advanced‐stage Hodgkin lymphoma.

Hodgkin lymphoma: is there really a need for interim and end‐of‐treatment FDG‐PET evaluations?

Overestimated value of FDG- PET based bone marrow evaluation in lymphoma.

Does end-of-treatment FDG- PET provide any additional prognostic value to the pre-treatment NCCN- IPI score?

Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis.

Prognostic value of complete remission status at end-oftreatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.

Pulmonary embolism in patients with COVID-19 and value of D-dimer assessment: a meta-analysis.

Pretransplant FDG- PET in aggressive non-Hodgkin lymphoma: systematic review and meta-analysis.

Controversies on the prognostic value of interim FDG- PET in advanced-stage Hodgkin lymphoma.

Peer review practices by medical imaging journals.

Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitis.

Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.

Direct comparison of visual and quantitative bone marrow FDG-PET/CT findings with bone marrow biopsy results in diffuse large B-cell lymphoma: does bone marrow FDG-PET/CT live up to its promise?

Are Researchers Willing to Share Their Published Manuscript?